SCHEMBL22914740

SCHEMBL22914740

CCc1ccc(N(c2ccc(C(C)=O)cc2)c2ccccc2O)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.46
KMT2A Q03164 2/20 0.43
ALDH1A1 P00352 2/20 0.42
HSD17B1 P14061 1/20 0.41
MAPT P10636 3/20 0.39
POLB P06746 2/20 0.39
MEN1 O00255 1/20 0.39
GAA P10253 1/20 0.39
MCL1 Q07820 1/20 0.39
NOX1 Q9Y5S8 1/20 0.39
PLK1 P53350 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
MAOB P27338 1/20 0.38
HTT P42858 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
TAS2R14 Q9NYV8 1/20 0.37
TAS1R3 Q7RTX0 1/20 0.37
TAS1R1 Q7RTX1 1/20 0.37
PYCR1 P32322 1/20 0.37
NR1I2 O75469 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21397389 0.91 MAPT (0.46) LMNAKMT2AALDH1A1HSD17B1MAPT
SCHEMBL21397724 0.88 MAPT (0.47) LMNAKMT2AALDH1A1HSD17B1MAPT
SCHEMBL21397725 0.81 NPC1 (0.46) KMT2AALDH1A1MAPTMEN1SMN1; SMN2
SCHEMBL21397726 0.81 NR1H4 (0.43) LMNAKMT2AALDH1A1MAPTPOLB
SCHEMBL334751 0.77 KMT2A (0.70) LMNAKMT2AALDH1A1HSD17B1MAPT
SCHEMBL29012584 0.72 MAPT (0.47) LMNAKMT2AALDH1A1MAPTPOLB
SCHEMBL1622617 0.71 KMT2A (0.61) LMNAKMT2AALDH1A1HSD17B1MAPT
SCHEMBL7050772 0.71 MAPT (0.59) LMNAKMT2AALDH1A1MAPTPOLB
Acetophenone SCHEMBL19875580 0.71 LMNA (0.64) LMNAKMT2AALDH1A1MAPTSMN1; SMN2
SCHEMBL29895062 0.71 MAPT (0.59) LMNAKMT2AALDH1A1MAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210024455-A1 COMPOUND WHICH INHIBITS TELOMERE-BINDING PROTEIN, AND TELOMERE-BINDING PROTEIN INHIBITOR CONTAINING SAME HIROSHIMA UNIVERSITY (JP) 2021-01-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210024455-A1 COMPOUND WHICH INHIBITS TELOMERE-BINDING PROTEIN, AND TELOMERE-BINDING PROTEIN INHIBITOR CONTAINING SAME TERF2IP, TERF2, POT1 LMNA 2257/4885KMT2A 1339/4885ALDH1A1 3723/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.